News

GPC negotiator announces gender change and is not re-elected

18-Jul-08

Stewart Drage at the LMC conference last month
GPC negotiator Dr Stewart Drage has revealed he has become a woman.

In a letter to Londonwide LMCs' members yesterday, Dr Drage said her new name is Michelle.

‘I am writing to inform you that after careful consideration and thought and with the support of my family, friends and colleagues, my name and gender has changed permanently from Stewart Drage to Michelle Drage with immediate effect,’ the letter says.

Dr Drage is also joint chief executive of Londonwide LMCs.

Despite standing for re-election as a negotiator at yesterday's meeting in London, Dr Drage lost out to Devon GP Dr Beth McCarron-Nash. The rest of the negotiating team remains unchanged.

Dr Drage said: 'Congratulations to Peter (Holden), Beth and Richard (Vautrey) and whilst it is disappointing for me personally, they can be assured of my continued support as an active member of the GPC.

'As joint chief executive officer of Londonwide LMCs I, along with my colleague Dr Tony Stanton, have a huge amount of work to do to ensure that general practice is not destabilised as a result of the major changes being planned and implemented across London's NHS. There will always be another election.'

nick.bostock@haymarket.com

Full text of Dr Drage's letter

Editor's blog: A gender for change
Comment below and tell us what you think

Comments

Rupen Kulkarni

17/07/2008

No comment.

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Quick search - use * for an abbreviated search, eg nico*

 
 

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs